$12.60
1.9117.87%
Pre-Market: Mar 26, 8:09 AM EDT
As of Feb 28, 2025
AdvisorShares Psychedelics ETF (ARCA: PSIL)
Ticker | Name | Share % | |
---|---|---|---|
CA | Mind Medicine Mindmed Inc | 8.40% | |
CMPS | Compass Pathways Plc Adr | 5.45% | |
GHRS | Gh Research Plc | 5.18% | |
NRXP | NRX Pharmaceuticals Inc. | 6.57% | |
ITCI | Intra-Cellular Therapies Inc | 5.82% | |
MU | Atai Life Sciences BV | 7.35% | |
ALKS | Alkermes Plc | 7.17% | |
VTGN | Vistagen Therapeutics Inc. | 5.00% | |
SAGE | Sage Therapeutics, Inc | 6.38% | |
STIM | Neuronetics Inc | 5.89% |
The PSIL ETF is currently trading at $10.69, which represents a 0.00% change. Over the past 52 weeks, the ETF has traded as high as $15.94 and as low as $0.80.
The expense ratio of PSIL is 0.99%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for PSIL is 7.98M. This represents the total market value of the assets managed by the ETF.
PSIL follows a Large Cap Value investment style.
The top holdings of PSIL include: CA (8.4%), CMPS (5.45%), GHRS (5.18%), NRXP (6.57%), ITCI (5.82%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for PSIL is currently not available.